Literature DB >> 23264163

Recurrent hypertensive intracerebral haemorrhages: what should we do when a new hemispheric ischaemic event strikes?

Osama S M Amin1.   

Abstract

Hypertensive intracerebral haemorrhage is usually a once in a lifetime event and recurrences are rare. Most recurrences usually develop within 2 years of the first event and the majority usually target the basal ganglia and thalami. Failure of blood pressure control is the most important, potentially preventable, culprit behind the development of primary intracerebral haemorrhages. However, the occurrence of a recurrent bleed in patients with optimally controlled hypertension should always prompt the physician to think of a new co-operating factor. We report on a 60-year-old hypertensive woman who developed right-sided thalamic haemorrhage 5 days after sustaining a lacunar infarct of the left thalamus for which she had been prescribed a dual antiplatelet therapy: aspirin and clopidrogrel. She had a history of two bilateral sequential hypertensive deep cerebellar haemorrhages which were developed 2 years ago.

Entities:  

Mesh:

Year:  2012        PMID: 23264163      PMCID: PMC4312781          DOI: 10.1136/bcr-2012-008079

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  21 in total

1.  Recurrent brain hemorrhage is more frequent than ischemic stroke after intracranial hemorrhage.

Authors:  R D Bailey; R G Hart; O Benavente; L A Pearce
Journal:  Neurology       Date:  2001-03-27       Impact factor: 9.910

2.  Clinical findings in patients with recurrent intracerebral hemorrhage.

Authors:  M Maruishi; T Shima; Y Okada; M Nishida; K Yamane; S Okita
Journal:  Surg Neurol       Date:  1995-11

3.  Effects of clopidogrel added to aspirin in patients with recent lacunar stroke.

Authors:  Oscar R Benavente; Robert G Hart; Leslie A McClure; Jeffrey M Szychowski; Christopher S Coffey; Lesly A Pearce
Journal:  N Engl J Med       Date:  2012-08-30       Impact factor: 91.245

Review 4.  Nontraumatic parenchymal brain hemorrhages.

Authors:  L A Weisberg; A Stazio; M Shamsnia; D Elliott
Journal:  Medicine (Baltimore)       Date:  1990-09       Impact factor: 1.889

Review 5.  Risk of hemorrhagic stroke with aspirin use: an update.

Authors:  Philip B Gorelick; Steven M Weisman
Journal:  Stroke       Date:  2005-07-14       Impact factor: 7.914

6.  Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial.

Authors:  Hans-Christoph Diener; Julien Bogousslavsky; Lawrence M Brass; Claudio Cimminiello; Laszlo Csiba; Markku Kaste; Didier Leys; Jordi Matias-Guiu; Hans-Jürgen Rupprecht
Journal:  Lancet       Date:  2004 Jul 24-30       Impact factor: 79.321

7.  Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials.

Authors:  J He; P K Whelton; B Vu; M J Klag
Journal:  JAMA       Date:  1998-12-09       Impact factor: 56.272

Review 8.  Combination antiplatelet therapy for secondary stroke prevention: enhanced efficacy or double trouble?

Authors:  M Haris U Usman; Lawrence A Notaro; Rangadham Nagarakanti; Eric Brahin; Scott Dessain; Edward Gracely; Michael D Ezekowitz
Journal:  Am J Cardiol       Date:  2009-03-04       Impact factor: 2.778

9.  The Harvard Cooperative Stroke Registry: a prospective registry.

Authors:  J P Mohr; L R Caplan; J W Melski; R J Goldstein; G W Duncan; J P Kistler; M S Pessin; H L Bleich
Journal:  Neurology       Date:  1978-08       Impact factor: 9.910

10.  Recurrent, sequential, bilateral deep cerebellar hemorrhages: a case report.

Authors:  Osama Sm Amin; Raz T Omer; Aso A Abdulla; Raz H Ahmed; Omed Ahmad; Soran Ahmad
Journal:  J Med Case Rep       Date:  2011-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.